Navidea Biopharmaceuticals Inc. (NAVB) Dipped -7.9% or -0.01 To Price $0.14 On Wednesday


Navidea Biopharmaceuticals Inc. (NAVB) dipped -7.9% or -0.01 to $0.14. It is near 169560 shares traded, which is 49.23% compare to the average total volume 344453. The market cap of NAVB is $22.50 million. The year to date change is -69.52%. The 52 week price range is from $0.13 to $0.68. Price of NAVB have changed -3.80% during last week. It have changed -25.73% over last month, -34.32% over last 3 months, -57.34% over last 6 months and -63.94% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NAVB is 0.20. It is 42.86% above current price. The 200-day Moving Averages for NAVB is 0.32. It is 128.57% above current price. The 52-week High is 0.68. It is 385.71% from the current price. The 52-week Low is 0.13. It is -7.14% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of NAVB is 14.81 on 2018-07-31. Short % to float is 3.35%. There are some statistics of NAVB. It is has market cap $22.50 million. The share outstanding is 163.62 million. The average volume is 344453. The percent of top 15 Institution holding is 7.70%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NAVB is -155.18%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NAVB is -84.37%.


Tags:

Share this post